Related Experiment Video
Updated: Oct 24, 2025
06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
11.4K
Prostate cancer: Molecular imaging and MRI
Farshad Moradi1, Andrea Farolfi2, Stefano Fanti2
1Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Stanford University, Stanford, CA, USA.
European Journal of Radiology
|August 14, 2021
Summary
Molecular imaging, particularly PET scans, offers superior diagnostic performance for prostate cancer detection and management compared to traditional methods. Ongoing research focuses on new radiopharmaceuticals to overcome challenges posed by variable tumor biology.
Area of Science:
- Nuclear Medicine
- Oncology
- Radiology
Background:
- Molecular imaging is increasingly vital for evaluating prostate cancer, showing improved diagnostic accuracy over anatomic imaging.
- Challenges remain due to diverse tumor biology, transmembrane protein expression, and metabolic variations.
- The field is rapidly evolving with new PET radiopharmaceuticals and hybrid imaging techniques.
Purpose of the Study:
- To review current evidence and controversies surrounding molecular imaging in prostate cancer.
- To emphasize emerging PET radiopharmaceuticals for prostate cancer diagnosis and management.
- To discuss the clinical utility of PET/CT and PET/MRI in prostate cancer workup.
Main Methods:
- Comprehensive literature review of molecular imaging in prostate cancer.
- Analysis of diagnostic performance of advanced imaging modalities.
- Focus on emerging positron emission tomography (PET) radiotracers and hybrid imaging (PET/CT, PET/MRI).
Main Results:
- Molecular imaging demonstrates superior diagnostic performance in initial prostate cancer evaluation and recurrence detection.
- Emerging PET radiopharmaceuticals show promise in overcoming biological heterogeneity challenges.
- PET/CT and PET/MRI offer significant clinical utility in managing prostate cancer patients.
Conclusions:
- Molecular imaging, especially PET-based techniques, is transforming prostate cancer diagnosis and management.
- Continued development of novel radiopharmaceuticals is crucial for addressing diagnostic challenges.
- PET/CT and PET/MRI are becoming indispensable tools for comprehensive prostate cancer care.
Related Concept Videos
01:27Imaging Studies IV: Magnetic Resonance Imaging
89
Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
89
01:24Magnetic Resonance Imaging
8.1K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
8.1K
01:29Positron Emission Tomography
6.3K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.3K
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
275
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
275